课题基金 / 基金详情

The Structural Basis of Antiarrhythmic Drug Binding in Voltage-gated Ion Channels

The Structural Basis of Antiarrhythmic Drug Binding in Voltage-gated Ion Channels
电压门控离子通道中抗心律失常药物结合的结构基础
批准号:
10558582
负责人:
MICHAEL J LENAEUS
金额:
$16.31万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-02-01 至 2024-01-31

项目摘要

项目成果

MICHAEL J LENAEUS的其他基金

相似基金

相关文献

中文摘要
翻译
摘要/项目摘要 心律失常影响着数百万美国人, 美国老年人的发病率和死亡率, 支出。他们有很多原因,包括遗传基因突变, 电解质紊乱和药物副作用-尽管所有这些原因都有 心肌中电压门控离子通道的失效。抗心律 抗心律失常药物(AAD)广泛用于治疗房性和室性心律失常, 虽然目前对这些渠道的了解有限, AAD在结构水平上的分子作用机制。在这份提案中,我的目标是 研究AAD在模型电压门控钠和钙通道中的作用,使用 广泛使用的钠通道阻滞剂AAD利多卡因和氟卡尼以及 广泛使用的钙通道阻滞剂AAD地尔硫卓。我将使用已建立的 电生理学和X射线晶体学技术来研究AAD, 与细菌电压门控钠和钙通道复合,而 致力于建立AAD结合位点的新结构模型, 串联细菌通道、高阶通道和Cryo-EM方法。我 我希望这些实验能更好地理解电压门控离子 通道生理学,并有助于设计更安全,更有效的AAD,以及 作为可用于治疗心房和心室 心律不齐
英文摘要
Abstract/Project Summary Cardiac arrhythmias affect millions of Americans and are a common cause of morbidity and mortality in older Americans, as well as health care expenditures. They have many causes including inherited gene mutations, electrolyte disturbances, and drug side effects—though all of these causes share the misfiring of voltage-gated ion channels in myocardium. Anti-arrhythmic drugs (AAD) are widely used to treat both atrial and ventricular arrhythmias by blocking such channels, though there is currently a limited understanding of the AAD molecular mechanism of action on a structural level. In this proposal, I aim to study AADs in model voltage-gated sodium and calcium channels, using the widely used sodium channel blocker AAD lidocaine and flecainide as well as the widely used calcium channel blocker AAD diltiazem. I will use established techniques of electrophysiology and X-ray crystallography to study AAD in complex with bacterial voltage-gated sodium and calcium channels, while working to establish new structural models of the AAD binding site using concatenated bacterial channels, higher order channels, and Cryo-EM methods. I expect these experiments to allow for a better understanding of voltage-gated ion channel physiology and aid in the design of safer and more effective AAD, as well as novel therapeutics that may be used for treatment of atrial and ventricular arrhythmias.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structural Basis of Potassium Channel Drug Interactions
Structural Basis of Potassium Channel Drug Interactions
Structural Basis of Potassium Channel Drug Interactions
海外基金